Search research articles
Contact Us
Filters
Showing results (51-60 of 103) with videos related to
Page
of 11
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 10, 2017
FDA Approval Summary: Pembrolizumab for the Treatment of Patients with Unresectable or Metastatic Melanoma
Amy Barone, Maitreyee Hazarika, Marc R Theoret, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 23, 2023
Considerations for Drug Development in Myelodysplastic Syndromes
Mikkael A Sekeres, Nina Kim, Amy E DeZern, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 12, 2022
Improving Dose-Optimization Processes Used in Oncology Drug Development to Minimize Toxicity and Maximize Benefit to Patients
Jeanne Fourie Zirkelbach, Mirat Shah, Jonathon Vallejo, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
April 19, 2023
FDA Analysis of Ineligibility for Acute Myeloid Leukemia Clinical Trials by Race and Ethnicity
Dianne Pulte, Laura Fernandes, Guo Wei, et al.
JAMA Oncology
|
January 6, 2022
Association of Radiation Therapy With Risk of Adverse Events in Patients Receiving Immunotherapy: A Pooled Analysis of Trials in the US Food and Drug Administration Database
Mitchell S Anscher, Shaily Arora, Chana Weinstock, et al.
Journal of Neuro-Oncology
|
June 22, 2021
US Food and Drug Administration regulatory updates in neuro-oncology
Gautam U Mehta, Amy K Barone, Diana Bradford, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 9, 2004
Vaccine-stimulated, adoptively transferred CD8+ T cells traffic indiscriminately and ubiquitously while mediating specific tumor destruction
Douglas C Palmer, Sanjeeve Balasubramaniam, Ken-Ichi Hanada, et al.
The Oncologist
|
May 31, 2022
FDA Approval Summary: Revised Indication and Dosing Regimen for Ponatinib Based on the Results of the OPTIC Trial
E Dianne Pulte, Haiyan Chen, Lauren S L Price, et al.
The Oncologist
|
March 9, 2021
FDA Approval Summary: Atezolizumab and Durvalumab in Combination with Platinum-Based Chemotherapy in Extensive Stage Small Cell Lung Cancer
Luckson Mathieu, Sujay Shah, Lee Pai-Scherf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 24, 2022
FDA Approval Summary: Oral Azacitidine for Continued Treatment of Adults with Acute Myeloid Leukemia Unable to Complete Intensive Curative Therapy
Emily Y Jen, Xin Wang, Meng Li, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 103) with videos related to
Sort By:
Page
of 11
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 10, 2017
FDA Approval Summary: Pembrolizumab for the Treatment of Patients with Unresectable or Metastatic Melanoma
Amy Barone, Maitreyee Hazarika, Marc R Theoret, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 23, 2023
Considerations for Drug Development in Myelodysplastic Syndromes
Mikkael A Sekeres, Nina Kim, Amy E DeZern, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 12, 2022
Improving Dose-Optimization Processes Used in Oncology Drug Development to Minimize Toxicity and Maximize Benefit to Patients
Jeanne Fourie Zirkelbach, Mirat Shah, Jonathon Vallejo, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
April 19, 2023
FDA Analysis of Ineligibility for Acute Myeloid Leukemia Clinical Trials by Race and Ethnicity
Dianne Pulte, Laura Fernandes, Guo Wei, et al.
JAMA Oncology
|
January 6, 2022
Association of Radiation Therapy With Risk of Adverse Events in Patients Receiving Immunotherapy: A Pooled Analysis of Trials in the US Food and Drug Administration Database
Mitchell S Anscher, Shaily Arora, Chana Weinstock, et al.
Journal of Neuro-Oncology
|
June 22, 2021
US Food and Drug Administration regulatory updates in neuro-oncology
Gautam U Mehta, Amy K Barone, Diana Bradford, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 9, 2004
Vaccine-stimulated, adoptively transferred CD8+ T cells traffic indiscriminately and ubiquitously while mediating specific tumor destruction
Douglas C Palmer, Sanjeeve Balasubramaniam, Ken-Ichi Hanada, et al.
The Oncologist
|
May 31, 2022
FDA Approval Summary: Revised Indication and Dosing Regimen for Ponatinib Based on the Results of the OPTIC Trial
E Dianne Pulte, Haiyan Chen, Lauren S L Price, et al.
The Oncologist
|
March 9, 2021
FDA Approval Summary: Atezolizumab and Durvalumab in Combination with Platinum-Based Chemotherapy in Extensive Stage Small Cell Lung Cancer
Luckson Mathieu, Sujay Shah, Lee Pai-Scherf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 24, 2022
FDA Approval Summary: Oral Azacitidine for Continued Treatment of Adults with Acute Myeloid Leukemia Unable to Complete Intensive Curative Therapy
Emily Y Jen, Xin Wang, Meng Li, et al.
Page
of 11